Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Thrombosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06302179
What this trial is testing

Risk Factors of Venous Thromboembolism After Colorectal Cancer Surgery

Who this might be right for
Colorectal CancerVenous Thromboembolism
Pirogov Russian National Research Medical University 137
Not applicableUnknownNCT05530785
What this trial is testing

Radiotherapy + Sintilimab + Bevacizumab Biosimilar for uHCC With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Yongchang Zhang 35
Not applicableStudy completedNCT03108248
What this trial is testing

ISP-TACE Versus TACE for HCC With PVTT

Who this might be right for
HCCPortal Vein Tumor Thrombosis
Zhongda Hospital 126
Large-scale testing (Phase 3)Looking for participantsNCT07493304
What this trial is testing

Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers

Who this might be right for
Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals 1,600
Large-scale testing (Phase 3)UnknownNCT02301091
What this trial is testing

Combine TACE and RFA Versus TACE Alone for HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma
Ming Zhao 240
Not applicableLooking for participantsNCT07315347
What this trial is testing

Home Treatment of Patients With Active Cancer and Acute Pulmonary Embolism Without HESTIA Criteria.

Who this might be right for
Active Cancer and Symptomatic or Incidental Pulmonary Embolism Without HESTIA Criteria
Assistance Publique - Hôpitaux de Paris 824
Testing effectiveness (Phase 2)Study completedNCT03282643
What this trial is testing

Rivaroxaban Versus Low-molecular-weight Heparin for Preventing Thrombosis in Cancer Patients

Who this might be right for
Neoplasms
Capital Medical University 74
Testing effectiveness (Phase 2)Study completedNCT03494816
What this trial is testing

Study of Axitinib for Reducing Extent of Venous Tumour Thrombus in Renal Cancer With Venous Invasion

Who this might be right for
Renal Cell CarcinomaMetastatic Renal Cell CarcinomaNon-metastatic Renal Cell Carcinoma
Scottish Clinical Trials Research Unit 24
Early research (Phase 1)Study completedNCT01325558
What this trial is testing

ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced Malignant NeoplasmMalignant Solid Tumour
Altor BioScience 30
Not applicableLooking for participantsNCT06714734
What this trial is testing

Thromboembolic and Hemorrhagic Complications of Anticoagulant Treatment in Patients With CAT

Who this might be right for
Venous Thromboembolism
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,000
Not applicableLooking for participantsNCT05589207
What this trial is testing

Predicting Model Based on Evidence-based Pathological Diagnose Criteria for RCC Tumor Thrombus With IVC Wall Invasion

Who this might be right for
Carcinoma, Renal CellTumor ThrombusNeoplasm Invasiveness+1 more
Peking University Third Hospital 232
Not applicableLooking for participantsNCT06386107
What this trial is testing

Thrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis

Who this might be right for
CancerPulmonary EmbolismThrombosis
Centre Hospitalier Universitaire de Saint Etienne 212
Not applicableLooking for participantsNCT06950697
What this trial is testing

Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

Who this might be right for
Lung CancerVenous ThromboembolismArterial Thromboembolism+1 more
Beijing Chao Yang Hospital 2,400
Post-approval studies (Phase 4)UnknownNCT04127396
What this trial is testing

Lenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTT

Who this might be right for
Carcinoma, HepatocellularPortal Vein Tumor Thrombus
Beijing Ditan Hospital 72
Post-approval studies (Phase 4)Looking for participantsNCT05255003
What this trial is testing

STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis

Who this might be right for
Cancer-associated ThrombosisThrombocytopenia
Tzu-Fei Wang 50
Large-scale testing (Phase 3)UnknownNCT03939845
What this trial is testing

A Prospective, Randomized, Multicenter Study of Comparison of TACE Combination With and Without EBRT for Hepatocellular Carcinoma With Portal Vein Tumor Thrombi

Who this might be right for
Carcinoma, Hepatocellular
Shanghai Zhongshan Hospital 180
Not applicableStudy completedNCT07388056
What this trial is testing

Efficacy and Safety of Extended Anticoagulant Therapy in Cancer Associated Thrombosis in Thai Population

Who this might be right for
Cancer-associated Thrombosis
Thammasat University 169
Not applicableActive Not RecruitingNCT06248528
What this trial is testing

Comparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy.

Who this might be right for
Hepatocellular Carcinoma
Chen Xiaoping 1,076
Testing effectiveness (Phase 2)Looking for participantsNCT06904183
What this trial is testing

Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 320
Post-approval studies (Phase 4)UnknownNCT03178656
What this trial is testing

A Trial to Compare Surgery With Sorafenib for Hepatic Celluler Cancer With Portal Vein Tumor Thrombosis

Who this might be right for
Portal Vein Tumor Thrombus
Huazhong University of Science and Technology 54
Next Page